ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria

Oxabact; Oxalobacter formigenes; Primary hyperoxaluria

Bibliographic Details
Authors:	Collard, Laure, Moochhala, Shabbir H., Gould, Edward, Boussetta, Abir, Fraga Rodriguez, Gloria Mª, ABROUG, Saoussen, Ariceta Iraola, Gema
Format:	article
Status:	Published version
Publication Date:	2023
Country:	España
Institution:	Departament de Salut de la Generalitat de Catalunya (DS)
Repository:	Scientia. Dipòsit d'Informació Digital del Departament de Salut
OAI Identifier:	oai:scientiasalut.gencat.cat:11351/8962
Online Access:	https://hdl.handle.net/11351/8962
Access Level:	Open access
Keyword:	Malalties congènites - Tractament Bacteris anaerobis Ronyons - Malalties - Tractament ORGANISMS::Bacteria::Gram-Negative Bacteria::Gram-Negative Anaerobic Bacteria::Gram-Negative Anaerobic Straight, Curved, and Helical Rods::Oxalobacter formigenes DISEASES::Congenital, Hereditary, and Neonatal Diseases and Abnormalities::Genetic Diseases, Inborn::Metabolism, Inborn Errors::Carbohydrate Metabolism, Inborn Errors::Hyperoxaluria, Primary Other subheadings::Other subheadings::/therapy ORGANISMOS::Bacteria::bacterias gramnegativas::bacterias anaerobias gramnegativas::bacilos anaerobios gramnegativos, rectos, curvos y espirales::Oxalobacter formigenes ENFERMEDADES::enfermedades y anomalías neonatales congénitas y hereditarias::enfermedades genéticas congénitas::alteraciones congénitas del metabolismo::trastornos congénitos del metabolismo de los carbohidratos::hiperoxaluria primaria Otros calificadores::Otros calificadores::/terapia

Description
Summary:	Oxabact; Oxalobacter formigenes; Primary hyperoxaluria